Matthew Link
Director · FibroBiologics, Inc.
- 2024
- Jun 24, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matthew Link files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Paul Badawi - $957K in SGHT purchases and sales in the last 12 months
- Alison Bauerlein - $666K in SGHT purchases and sales in the last 12 months
- Jeremy B. Hayden - $635K in SGHT purchases and sales in the last 12 months
- David Badawi - $245K in SGHT purchases and sales in the last 12 months
- James Rodberg - $203K in SGHT purchases and sales in the last 12 months
- Staffan Encrantz - $185K in SGHT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew Link?
Matthew Link is a corporate insider, tracked as Director of FibroBiologics, Inc. (FBLG). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Matthew Link last file a Form 4?
The most recent primary Form 4 on record is dated 24 June 2026, one of 5 filings going back to 2024.
Has Matthew Link been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($510K) across all tracked filings.
